Integra LifeSciences Holdings Corporation (IART)
USD 19.49
(-2.84%)
USD 19.49
(-2.84%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 67.74 Million USD | -62.48% |
| 2022 | 180.55 Million USD | 6.79% |
| 2021 | 169.07 Million USD | 26.28% |
| 2020 | 133.89 Million USD | 166.71% |
| 2019 | 50.2 Million USD | -17.43% |
| 2018 | 60.8 Million USD | -6.09% |
| 2017 | 64.74 Million USD | -13.17% |
| 2016 | 74.56 Million USD | 2218.9% |
| 2015 | -3.51 Million USD | -110.35% |
| 2014 | 34 Million USD | 300.29% |
| 2013 | -16.97 Million USD | -141.2% |
| 2012 | 41.2 Million USD | 47.21% |
| 2011 | 27.98 Million USD | -57.38% |
| 2010 | 65.66 Million USD | 28.88% |
| 2009 | 50.95 Million USD | 45.86% |
| 2008 | 34.93 Million USD | 4.37% |
| 2007 | 33.47 Million USD | 13.82% |
| 2006 | 29.4 Million USD | -20.94% |
| 2005 | 37.19 Million USD | 116.28% |
| 2004 | 17.19 Million USD | -35.98% |
| 2003 | 26.86 Million USD | -23.86% |
| 2002 | 35.27 Million USD | 34.84% |
| 2001 | 26.16 Million USD | 329.0% |
| 2000 | -11.42 Million USD | -90.42% |
| 1999 | -6 Million USD | 51.22% |
| 1998 | -12.3 Million USD | 27.65% |
| 1997 | -17 Million USD | -126.67% |
| 1996 | -7.5 Million USD | 70.47% |
| 1995 | -25.4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -10.69 Million USD | 13.76% |
| 2024 Q1 | -3.28 Million USD | -116.54% |
| 2024 Q2 | -12.4 Million USD | -277.99% |
| 2023 Q4 | 19.83 Million USD | 1.73% |
| 2023 Q1 | 24.22 Million USD | -54.24% |
| 2023 FY | 67.74 Million USD | -62.48% |
| 2023 Q3 | 19.49 Million USD | 365.99% |
| 2023 Q2 | 4.18 Million USD | -82.73% |
| 2022 FY | 180.55 Million USD | 6.79% |
| 2022 Q3 | 49.91 Million USD | 11.45% |
| 2022 Q4 | 52.94 Million USD | 6.07% |
| 2022 Q2 | 44.78 Million USD | 36.13% |
| 2022 Q1 | 32.9 Million USD | -27.51% |
| 2021 Q1 | 45.39 Million USD | -51.05% |
| 2021 Q3 | 43.22 Million USD | 23.27% |
| 2021 Q4 | 45.38 Million USD | 4.99% |
| 2021 FY | 169.07 Million USD | 26.28% |
| 2021 Q2 | 35.06 Million USD | -22.75% |
| 2020 Q1 | 9.18 Million USD | -40.07% |
| 2020 Q3 | 32.33 Million USD | 8863.41% |
| 2020 Q4 | 92.74 Million USD | 186.8% |
| 2020 FY | 133.89 Million USD | 166.71% |
| 2020 Q2 | -369 Thousand USD | -104.02% |
| 2019 Q2 | 29.73 Million USD | -9.22% |
| 2019 Q3 | -27.61 Million USD | -192.85% |
| 2019 Q4 | 15.31 Million USD | 155.48% |
| 2019 FY | 50.2 Million USD | -17.43% |
| 2019 Q1 | 32.75 Million USD | 30.3% |
| 2018 Q4 | 25.13 Million USD | 89.08% |
| 2018 Q2 | 11.37 Million USD | 3.49% |
| 2018 Q1 | 10.99 Million USD | -75.22% |
| 2018 FY | 60.8 Million USD | -6.09% |
| 2018 Q3 | 13.29 Million USD | 16.87% |
| 2017 Q2 | 10.83 Million USD | 69.46% |
| 2017 Q3 | 3.15 Million USD | -70.84% |
| 2017 Q4 | 44.35 Million USD | 1304.08% |
| 2017 FY | 64.74 Million USD | -13.17% |
| 2017 Q1 | 6.39 Million USD | -77.36% |
| 2016 Q3 | 20.14 Million USD | 57.93% |
| 2016 Q4 | 28.24 Million USD | 40.22% |
| 2016 FY | 74.56 Million USD | 2218.9% |
| 2016 Q2 | 12.75 Million USD | 9.5% |
| 2016 Q1 | 11.64 Million USD | -22.24% |
| 2015 Q4 | 14.98 Million USD | 146.99% |
| 2015 Q1 | 8.38 Million USD | -51.16% |
| 2015 Q2 | 4.99 Million USD | -40.39% |
| 2015 Q3 | -31.88 Million USD | -737.88% |
| 2015 FY | -3.51 Million USD | -110.35% |
| 2014 Q4 | 17.16 Million USD | 75.04% |
| 2014 Q3 | 9.8 Million USD | 103.25% |
| 2014 FY | 34 Million USD | 300.29% |
| 2014 Q1 | 2.2 Million USD | -81.89% |
| 2014 Q2 | 4.82 Million USD | 118.72% |
| 2013 Q2 | 3.44 Million USD | 184.94% |
| 2013 Q4 | 12.18 Million USD | 142.67% |
| 2013 FY | -16.97 Million USD | -141.2% |
| 2013 Q1 | -4.05 Million USD | -131.68% |
| 2013 Q3 | -28.55 Million USD | -929.94% |
| 2012 Q2 | 8.51 Million USD | 27.21% |
| 2012 Q3 | 13.21 Million USD | 55.17% |
| 2012 Q4 | 12.78 Million USD | -3.22% |
| 2012 FY | 41.2 Million USD | 47.21% |
| 2012 Q1 | 6.69 Million USD | 46.78% |
| 2011 Q3 | 11.24 Million USD | 1508.44% |
| 2011 Q1 | 11.48 Million USD | -38.92% |
| 2011 Q2 | 699 Thousand USD | -93.91% |
| 2011 Q4 | 4.56 Million USD | -59.44% |
| 2011 FY | 27.98 Million USD | -57.38% |
| 2010 Q3 | 16.48 Million USD | 8.75% |
| 2010 Q1 | 15.22 Million USD | -3.24% |
| 2010 FY | 65.66 Million USD | 28.88% |
| 2010 Q4 | 18.8 Million USD | 14.1% |
| 2010 Q2 | 15.15 Million USD | -0.43% |
| 2009 Q4 | 15.73 Million USD | 9.0% |
| 2009 Q1 | 9.56 Million USD | -61.49% |
| 2009 Q2 | 11.22 Million USD | 17.33% |
| 2009 FY | 50.95 Million USD | 45.86% |
| 2009 Q3 | 14.43 Million USD | 28.57% |
| 2008 Q4 | 24.84 Million USD | 262.48% |
| 2008 FY | 34.93 Million USD | 4.37% |
| 2008 Q3 | -15.29 Million USD | -210.69% |
| 2008 Q2 | 13.81 Million USD | 19.45% |
| 2008 Q1 | 11.56 Million USD | 114.88% |
| 2007 FY | 33.47 Million USD | 13.82% |
| 2007 Q4 | 5.38 Million USD | -44.36% |
| 2007 Q3 | 9.67 Million USD | 3.55% |
| 2007 Q1 | 9.07 Million USD | -10.43% |
| 2007 Q2 | 9.34 Million USD | 2.94% |
| 2006 Q2 | 7.97 Million USD | -8.36% |
| 2006 Q3 | 2.59 Million USD | -67.48% |
| 2006 Q4 | 10.13 Million USD | 290.56% |
| 2006 FY | 29.4 Million USD | -20.94% |
| 2006 Q1 | 8.7 Million USD | -17.99% |
| 2005 FY | 37.19 Million USD | 116.28% |
| 2005 Q4 | 10.61 Million USD | 1.27% |
| 2005 Q1 | 8.44 Million USD | -14.19% |
| 2005 Q2 | 7.65 Million USD | -9.33% |
| 2005 Q3 | 10.48 Million USD | 36.92% |
| 2004 Q1 | 7.43 Million USD | -18.91% |
| 2004 Q4 | 9.83 Million USD | 229.51% |
| 2004 Q3 | -7.59 Million USD | -201.05% |
| 2004 Q2 | 7.51 Million USD | 1.08% |
| 2004 FY | 17.19 Million USD | -35.98% |
| 2003 Q1 | 5.43 Million USD | -78.57% |
| 2003 FY | 26.86 Million USD | -23.86% |
| 2003 Q4 | 9.17 Million USD | 34.23% |
| 2003 Q3 | 6.83 Million USD | 26.12% |
| 2003 Q2 | 5.41 Million USD | -0.37% |
| 2002 Q4 | 25.37 Million USD | 1523.42% |
| 2002 FY | 35.27 Million USD | 34.84% |
| 2002 Q1 | 4.09 Million USD | -76.79% |
| 2002 Q2 | 4.24 Million USD | 3.86% |
| 2002 Q3 | 1.56 Million USD | -63.21% |
| 2001 FY | 26.16 Million USD | 329.0% |
| 2001 Q2 | 2.76 Million USD | 38.38% |
| 2001 Q3 | 3.78 Million USD | 36.86% |
| 2001 Q4 | 17.62 Million USD | 366.27% |
| 2001 Q1 | 1.99 Million USD | 116.41% |
| 2000 Q1 | -1.06 Million USD | -32.88% |
| 2000 Q3 | 1.71 Million USD | 1944.05% |
| 2000 Q4 | -12.16 Million USD | -808.39% |
| 2000 FY | -11.42 Million USD | -90.42% |
| 2000 Q2 | 84 Thousand USD | 107.9% |
| 1999 Q1 | 400 Thousand USD | 113.79% |
| 1999 Q3 | -2 Million USD | 44.44% |
| 1999 Q4 | -800 Thousand USD | 60.0% |
| 1999 FY | -6 Million USD | 51.22% |
| 1999 Q2 | -3.6 Million USD | -1000.0% |
| 1998 FY | -12.3 Million USD | 27.65% |
| 1998 Q3 | -2.9 Million USD | 9.38% |
| 1998 Q4 | -2.9 Million USD | 0.0% |
| 1998 Q1 | -3.3 Million USD | 69.16% |
| 1998 Q2 | -3.2 Million USD | 3.03% |
| 1997 Q2 | -2 Million USD | -11.11% |
| 1997 FY | -17 Million USD | -126.67% |
| 1997 Q4 | -10.7 Million USD | -328.0% |
| 1997 Q3 | -2.5 Million USD | -25.0% |
| 1997 Q1 | -1.8 Million USD | 21.74% |
| 1996 FY | -7.5 Million USD | 70.47% |
| 1996 Q1 | -1.6 Million USD | 27.27% |
| 1996 Q2 | -1.5 Million USD | 6.25% |
| 1996 Q3 | -2.1 Million USD | -40.0% |
| 1996 Q4 | -2.3 Million USD | -9.52% |
| 1995 Q4 | -2.2 Million USD | 89.52% |
| 1995 FY | -25.4 Million USD | 0.0% |
| 1995 Q3 | -21 Million USD | -1809.09% |
| 1995 Q2 | -1.1 Million USD | 0.0% |
| 1995 Q1 | -1.1 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 209.937% |
| BrainsWay Ltd. | -4.19 Million USD | 1714.034% |
| Cerus Corporation | -37.48 Million USD | 280.696% |
| Envoy Medical, Inc. | -29.9 Million USD | 326.498% |
| electroCore, Inc. | -18.83 Million USD | 459.674% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 865.435% |
| IceCure Medical Ltd | -14.65 Million USD | 562.333% |
| Inogen, Inc. | -102.44 Million USD | 166.122% |
| OrthoPediatrics Corp. | -20.97 Million USD | 422.976% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 228.624% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 592.833% |
| MaxCyte, Inc. | -37.92 Million USD | 278.628% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 671.197% |
| Nexalin Technology, Inc. | -4.64 Million USD | 1557.2% |
| Orthofix Medical Inc. | -151.39 Million USD | 144.745% |
| PAVmed Inc | -64.17 Million USD | 205.557% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 229.112% |
| RxSight, Inc. | -48.6 Million USD | 239.362% |
| Sight Sciences, Inc. | -55.54 Million USD | 221.953% |
| SI-BONE, Inc. | -43.33 Million USD | 256.316% |
| TELA Bio, Inc. | -46.66 Million USD | 245.168% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 236.776% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 598.719% |
| Acutus Medical, Inc. | -81.66 Million USD | 182.952% |
| Talis Biomedical Corporation | -62 Million USD | 209.247% |
| Spectral AI, Inc. | -20.85 Million USD | 424.835% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 211.46% |
| CVRx, Inc. | -41.19 Million USD | 264.424% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -10481.291% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 718.34% |
| Bioventus Inc. | -156.23 Million USD | 143.36% |
| Venus Concept Inc. | -37.25 Million USD | 281.855% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 214.741% |
| LivaNova PLC | 17.54 Million USD | -286.077% |
| 908 Devices Inc. | -36.39 Million USD | 286.107% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 136.295% |
| Nemaura Medical Inc. | -14.14 Million USD | 578.947% |
| NeuroPace, Inc. | -32.95 Million USD | 305.55% |
| LENSAR, Inc. | -14.38 Million USD | 570.98% |
| Apyx Medical Corporation | -18.71 Million USD | 462.0% |
| Cutera, Inc. | -162.83 Million USD | 141.602% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 725.494% |
| BioSig Technologies, Inc. | -29.04 Million USD | 333.26% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 181.944% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 406.673% |
| Axonics, Inc. | -6.08 Million USD | 1212.697% |
| Outset Medical, Inc. | -172.79 Million USD | 139.203% |
| IRIDEX Corporation | -9.57 Million USD | 807.847% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 163.969% |
| IRadimed Corporation | 17.19 Million USD | -294.009% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 921.701% |
| INVO Bioscience, Inc. | -8.03 Million USD | 943.115% |
| Telesis Bio, Inc. | -47.72 Million USD | 241.943% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -561.339% |
| Varex Imaging Corporation | -47.7 Million USD | 242.015% |
| Quipt Home Medical Corp. | -2.78 Million USD | 2533.226% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 700.222% |
| Pulmonx Corporation | -60.84 Million USD | 211.337% |
| Dynatronics Corporation | -2.69 Million USD | 2611.047% |
| Modular Medical, Inc. | -17.47 Million USD | 487.756% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 694.898% |
| Semler Scientific, Inc. | 20.58 Million USD | -229.111% |
| InMode Ltd. | 197.91 Million USD | 65.773% |
| Bruker Corporation | 427.2 Million USD | 84.143% |
| Cytosorbents Corporation | -28.5 Million USD | 337.626% |
| DexCom, Inc. | 541.5 Million USD | 87.49% |
| Align Technology, Inc. | 445.05 Million USD | 84.779% |
| Viveve Medical, Inc. | -22.02 Million USD | 407.536% |
| ZimVie Inc. | -393.28 Million USD | 117.225% |
| Movano Inc. | -29.28 Million USD | 331.332% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 657.631% |
| Nexalin Technology, Inc. | -4.64 Million USD | 1557.2% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -10481.291% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 130.43% |
| Profound Medical Corp. | -28.56 Million USD | 337.114% |
| Insulet Corporation | 206.3 Million USD | 67.164% |
| enVVeno Medical Corporation | -23.51 Million USD | 388.063% |
| Surmodics, Inc. | -11.54 Million USD | 686.909% |
| iCAD, Inc. | -4.84 Million USD | 1497.586% |
| Nuwellis, Inc. | -20.2 Million USD | 435.202% |
| Biotricity, Inc. | -14.09 Million USD | 580.627% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 154.893% |
| Aethlon Medical, Inc. | -12.2 Million USD | 654.882% |
| InspireMD, Inc. | -19.91 Million USD | 440.134% |
| PAVmed Inc. | -64.17 Million USD | 205.557% |
| BIOLASE, Inc. | -20.63 Million USD | 428.33% |
| Beyond Air, Inc. | -60.24 Million USD | 212.448% |
| FONAR Corporation | 10.56 Million USD | -541.038% |
| AxoGen, Inc. | -21.71 Million USD | 411.941% |
| Vivani Medical, Inc. | -25.65 Million USD | 364.077% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | -137.563% |
| Inari Medical, Inc. | -1.63 Million USD | 4240.648% |
| UFP Technologies, Inc. | 44.92 Million USD | -50.79% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 1419.887% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 1125.57% |
| Tenon Medical, Inc. | -15.58 Million USD | 534.767% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 539.135% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 291.722% |
| AdaptHealth Corp. | -678.89 Million USD | 109.978% |
| Sintx Technologies, Inc. | -8.25 Million USD | 920.208% |
| NanoVibronix, Inc. | -3.71 Million USD | 1925.411% |
| Quanterix Corporation | -32.33 Million USD | 309.504% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 700.222% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -13867.216% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 122.085% |
| TransMedics Group, Inc. | -25.02 Million USD | 370.661% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 406.063% |
| NeuroMetrix, Inc. | -6.52 Million USD | 1137.463% |
| Hyperfine, Inc. | -44.23 Million USD | 253.129% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 186.292% |
| Biomerica, Inc. | -5.97 Million USD | 1233.172% |
| Bone Biologics Corporation | -8.94 Million USD | 856.99% |
| AVITA Medical, Inc. | -39.16 Million USD | 272.949% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 780.548% |
| Silk Road Medical, Inc | -55.74 Million USD | 221.524% |